For millions of Americans living with depression, the search for effective treatment can feel like an uphill battle. However, two innovative treatments are generating significant clinical interest: Auvelity, an innovative oral antidepressant approved by the FDA in 2022, and ketamine, a rapid-acting therapy that has been transforming the treatment of depression for over two
June 18, 2026
